Automate Your Wheel Strategy on HUM
With Tiblio's Option Bot, you can configure your own wheel strategy including HUM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HUM
- Rev/Share 1021.3292
- Book/Share 151.7766
- PB 1.818
- Debt/Equity 0.6902
- CurrentRatio 0.0
- ROIC 0.1014
- MktCap 33075980719.0
- FreeCF/Share 20.2341
- PFCF 13.5613
- PE 21.0339
- Debt/Assets 0.2499
- DivYield 0.0129
- ROE 0.0902
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | HUM | Goldman | -- | Sell | -- | $235 | Oct. 14, 2025 |
| Initiation | HUM | Evercore ISI | -- | In-line | -- | $295 | Sept. 22, 2025 |
| Upgrade | HUM | Raymond James | Market Perform | Outperform | -- | $315 | May 1, 2025 |
| Initiation | HUM | KeyBanc Capital Markets | -- | Sector Weight | -- | -- | Oct. 11, 2024 |
| Upgrade | HUM | Bernstein | Market Perform | Outperform | -- | $308 | Oct. 8, 2024 |
| Downgrade | HUM | Jefferies | Buy | Hold | $519 | $253 | Oct. 7, 2024 |
| Downgrade | HUM | TD Cowen | Buy | Hold | $402 | $261 | Oct. 7, 2024 |
| Downgrade | HUM | Piper Sandler | Overweight | Neutral | $392 | $274 | Oct. 3, 2024 |
| Downgrade | HUM | Leerink Partners | Outperform | Market Perform | $400 | $250 | Oct. 2, 2024 |
| Downgrade | HUM | BofA Securities | Neutral | Underperform | $376 | $247 | Oct. 2, 2024 |
News
Humana Announces 2026 Medicare Advantage Plans Designed with Veterans in Mind
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana announces 2026 Medicare Advantage plans designed with veterans in mind. Humana USAA Honor Giveback Plans elevate mental health support.
Read More
Humana and Providence Launch Innovative Data Exchange Collaboration to Advance Value-Based Care
Published: October 20, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Providence launch innovative data exchange collaboration to advance value-based care.
Read More
Are Investors Undervaluing Humana (HUM) Right Now?
Published: October 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Humana (HUM) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Published: October 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
After losing some value lately, a hammer chart pattern has been formed for Humana (HUM), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Read More
Humana Loses Court Battle Over Medicare Advantage Ratings, Billions In Payments At Risk
Published: October 14, 2025 by: Benzinga
Sentiment: Negative
Humana Inc. (NYSE:HUM) lost a legal battle challenging cuts to its Medicare Advantage bonus payments, raising concerns over billions in potential revenue.
Read More
Humana loses challenge to 2025 Medicare Advantage ratings
Published: October 14, 2025 by: Reuters
Sentiment: Negative
A U.S. judge on Tuesday rejected Humana's bid to challenge the Centers for Medicare & Medicaid Services' 2025 ratings for its Medicare Advantage programs, which could cost the company millions in bonus payments from the government.
Read More
Why Humana (HUM) is a Top Value Stock for the Long-Term
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
HUMANA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Published: October 08, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Humana (HUM) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Humana between July 27, 2022, to January 24, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
Read More
Humana (HUM) Moves 4.0% Higher: Will This Strength Last?
Published: October 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana (HUM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Read More
Is Humana (HUM) Stock Undervalued Right Now?
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Humana Extends TailorCare Tie-Up to Enhance MA Member Health
Published: September 24, 2025 by: Zacks Investment Research
Sentiment: Positive
HUM expands its TailorCare partnership to Dallas and Denver, aiming to boost MA member health and cut MSK-related costs.
Read More
2 HMO Stocks Poised to Thrive Despite Escalating Medical Costs
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
The Medical-HMO industry benefits from strength in commercial plans, M&A and expected Medicare rate hikes, but rising costs, regulatory shifts and workforce shortages strain margins. CI and HUM are likely to navigate industry storms.
Read More
Humana Wins TVH Assets in Bankruptcy Sale, But Cut Points Drag Shares
Published: September 10, 2025 by: Zacks Investment Research
Sentiment: Neutral
Humana Inc. HUM, through its healthcare services businessCenterWell, has won court approval to acquire the assets of The Villages Health (“TVH”), a well-known medical group in Florida. The deal marks another step in Humana's effort to expand its senior-focused primary care platform and strengthen ties to its Medicare Advantage (MA) membership base.
Read More
Why Is Humana (HUM) Up 19.2% Since Last Earnings Report?
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
Read More
HUM Expands Musculoskeletal Care Access With New Value-Based Tie-Ups
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Humana teams up with Vori Health, HOPCo and TailorCare to expand value-based musculoskeletal care for Medicare Advantage members.
Read More
Here's Why Humana (HUM) is a Strong Value Stock
Published: August 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Humana Announces New Agreements to Expand Specialized Care Programs for Patients Living with Musculoskeletal Conditions
Published: August 27, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana announces new agreements to expand specialized care programs for patients living with musculoskeletal conditions.
Read More
New Research from Humana Finds Value-Based Care Delivers Higher Quality of Care for Heart Failure Patients
Published: August 21, 2025 by: Business Wire
Sentiment: Neutral
LOUISVILLE, Ky.--(BUSINESS WIRE)--Value-based care delivers a higher quality of care and better medication prescription adherence to evidence-based medicine for Medicare Advantage patients diagnosed with heart failure, according to findings released today by leading health and well-being company Humana Inc. (NYSE: HUM) in its latest Value-Based Care Issue Brief. Heart failure continues to affect a growing number of Americans, with 11.4 million expected to be diagnosed by 2050. Patients with hea.
Read More
CNC vs. HUM: Which Managed-Care Stock is a Smarter Investment?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Humana's strong Medicare Advantage growth and higher ROE give it an edge over Centene, which faces earnings pressure and OBBB Act headwinds.
Read More
Here's Why Humana (HUM) is a Strong Momentum Stock
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Humana (HUM) is a Strong Value Stock
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Why Humana (HUM) is a Top Momentum Stock for the Long-Term
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Negative
Humana's Q2 earnings fall year over year on a declining membership base. Notably, 2025 adjusted EPS is currently forecasted at around $17.00, up from the earlier view of around $16.25.
Read More
Humana Inc. (HUM) Q2 2025 Earnings Call Transcript
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Neutral
Humana Inc. (NYSE:HUM ) Q2 2025 Earnings Conference Call July 30, 2025 8:00 AM ET Company Participants Celeste Marie Mellet - Chief Financial Officer George Renaudin - President of Insurance James A. Rechtin - President, CEO & Director Lisa M.
Read More
Top Stock Movers Now: Humana, Hershey, VF Corp., and More
Published: July 30, 2025 by: Investopedia
Sentiment: Positive
U.S. equities were mixed at midday as the market responded to the U.S. economy growing more than expected in the second quarter while waiting for today's decision by the Federal Reserve on interest rates. The S&P 500 and Nasdaq gained, but the Dow Jones Industrial Average fell.
Read More
Humana Boosts Outlook on Lower-Than-Expected Medicare Advantage Membership Drop
Published: July 30, 2025 by: Investopedia
Sentiment: Positive
Humana (HUM) shares took off Wednesday when the health insurer boosted its guidance as it sees fewer losses of Medicare Advantage customers than previously thought.
Read More
Here's What Key Metrics Tell Us About Humana (HUM) Q2 Earnings
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Humana (HUM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Humana (HUM) Q2 Earnings Lag Estimates
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Negative
Humana (HUM) came out with quarterly earnings of $6.27 per share, missing the Zacks Consensus Estimate of $6.32 per share. This compares to earnings of $6.96 per share a year ago.
Read More
Has Humana turned the corner? Stock jumps as outlook raised, Medicare business improves
Published: July 30, 2025 by: Market Watch
Sentiment: Positive
Humana's stock surges, after the health insurer raises its full-year profit outlook and sees improvement in its Medicare Advantage business.
Read More
Insurer Humana raises annual profit forecast, shares climb
Published: July 30, 2025 by: Reuters
Sentiment: Positive
Humana raised its annual profit forecast on Wednesday, as the U.S. health insurer bets on its efforts to rein in higher medical costs that have plagued the sector, sending its shares up nearly 6% in premarket trading.
Read More
About Humana Inc. (HUM)
- IPO Date 1981-12-31
- Website https://www.humana.com
- Industry Medical - Healthcare Plans
- CEO James A. Rechtin
- Employees 65680